Skip Navigation


Hum. Reprod. Advance Access first published online on August 26, 2005
This version published online on September 9, 2005
Human Reproduction, doi:10.1093/humrep/dei248
This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
20/12/3500    most recent
dei248v2
dei248v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Luconi, M.
Right arrow Articles by Baldi, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luconi, M.
Right arrow Articles by Baldi, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved.
Received March 21, 2005
Revised June 28, 2005
Accepted July 14, 2005

Article

Enhancement of mouse sperm motility by the PI3-kinase inhibitor LY294002 does not result in toxic effects on preimplantation embryo development

Michaela Luconi 1, Simona Torcia 2, Domenico Grillo 2, Maria Teresa Fiorenza 2, Gianni Forti 1, Franco Mangia 2, and Elisabetta Baldi 1*

1 Department of Clinical Physiopathology, Center of Research, Transfer and High Education, ‘DENOthe’ Andrology Unit, University of Florence, Rome, Italy
2 Department of Psychology, Section of Neuroscience, University of Rome La Sapienza, Rome, Italy

* To whom correspondence should be addressed.
Elisabetta Baldi, E-mail: e.baldi{at}dfc.unifi.it


  Abstract

BACKGROUND: A reduced number of progressively motile sperm (as may occur in cases of asthenozoospermia or when cryopreserved spermatozoa are used for fertilization) limits the possibility of applying various assisted reproductive techniques (ARTs). We previously showed that incubation of sperm with the phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 increases sperm progressive motility and enhances the number of sperm recovered by capacitation protocols used in ART. METHODS AND RESULTS: In the present study, we investigate the motility-enhancing effects of this compound in epididymal mouse sperm, and examine the use of the mouse system to investigate the effect of LY294002 on oocyte fertilization and preimplantation embryo development. Our results show that neither pre-incubation of mouse spermatozoa with the inhibitor during in vitro capacitation nor the direct addition of LY294002 to the sperm-oocyte mixture significantly affects the process of fertilization and preimplantation development of embryos produced even when they developed in the presence of LY294002. CONCLUSIONS: The present data encourage the design of new drugs based on the molecular structure of LY294002, which may open up new options for the in vitro treatment of human/animal asthenozoospermia.

Keywords: embryo/phosphatidylinositol-3 kinase/sperm motility.

M.Luconi and S.Torcia contributed equally to this work and they should be regarded as joint First Authors


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.